首页 > 最新文献

Journal of Natural Medicines最新文献

英文 中文
Exploring anti-hyperglycemic potential of Pseuderanthemum crenulatum: isolation, structural elucidation and α-glucosidase inhibition evaluation 探讨假菊的降糖潜能:分离、结构鉴定及α-葡萄糖苷酶抑制作用评价。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2025-04-23 DOI: 10.1007/s11418-025-01907-5
Dung V. Ngo, Le-Thu T. Nguyen, Ngoc T. N. Ngo, Lien-Hoa D. Nguyen, Binh T. D. Trinh

Pseuderanthemum crenulatum (Acanthaceae) is a medicinal plant traditionally used to manage diabetes. However, its chemical constituents remain unexplored as no studies have been conducted on this species to date. This study aimed to chemically characterize and evaluate the anti-hyperglycemic activity of compounds isolated from the stems and roots of P. crenulatum. The isolation process involved utilizing column chromatography techniques, while structures were characterized mainly by 1D and 2D NMR experiments. Anti-hyperglycemic activity was evaluated by measuring their inhibitory effects on the α-glucosidase enzyme. Following this, a new abietane-type dinorditerpenoid, namely pseuderanthemone (1), along with ten known compounds (211), was isolated from an ethyl acetate extract of the stems and roots of P. crenulatum. The investigation into their anti-hyperglycemic effects revealed that compounds 1–3, and 6–10 showed higher α-glucosidase inhibitory activity than positive control, acarbose. Among them, compound 9 demonstrated the most potent activity, with an IC50 value nearly ten times lower than acarbose. Furthermore, kinetic analysis showed that compound 2 displayed mixed-type inhibition, and compound 3 demonstrated uncompetitive inhibition while the remaining compounds exhibited competitive inhibition.

Graphical Abstract

假菊(棘科)是一种传统上用于治疗糖尿病的药用植物。然而,其化学成分仍未被探索,因为迄今为止还没有对该物种进行过研究。本研究旨在化学表征和评价从crenulatum茎和根中分离的化合物的抗高血糖活性。分离过程涉及柱层析技术,而结构主要通过一维和二维核磁共振实验表征。通过测定其对α-葡萄糖苷酶的抑制作用来评价其抗高血糖活性。在此基础上,从crenulatum茎和根的乙酸乙酯萃取物中分离出一种新的二萜类化合物pseudoeranthemone(1)和10个已知化合物(2-11)。对其抗高血糖作用的研究表明,化合物1 ~ 3和6 ~ 10比阳性对照阿卡波糖具有更高的α-葡萄糖苷酶抑制活性。其中化合物9的活性最强,IC50值比阿卡波糖低近10倍。此外,动力学分析表明,化合物2表现为混合型抑制,化合物3表现为非竞争性抑制,其余化合物表现为竞争性抑制。
{"title":"Exploring anti-hyperglycemic potential of Pseuderanthemum crenulatum: isolation, structural elucidation and α-glucosidase inhibition evaluation","authors":"Dung V. Ngo,&nbsp;Le-Thu T. Nguyen,&nbsp;Ngoc T. N. Ngo,&nbsp;Lien-Hoa D. Nguyen,&nbsp;Binh T. D. Trinh","doi":"10.1007/s11418-025-01907-5","DOIUrl":"10.1007/s11418-025-01907-5","url":null,"abstract":"<div><p><i>Pseuderanthemum crenulatum</i> (Acanthaceae) is a medicinal plant traditionally used to manage diabetes. However, its chemical constituents remain unexplored as no studies have been conducted on this species to date. This study aimed to chemically characterize and evaluate the anti-hyperglycemic activity of compounds isolated from the stems and roots of <i>P. crenulatum</i>. The isolation process involved utilizing column chromatography techniques, while structures were characterized mainly by 1D and 2D NMR experiments. Anti-hyperglycemic activity was evaluated by measuring their inhibitory effects on the <i>α</i>-glucosidase enzyme. Following this, a new abietane-type dinorditerpenoid, namely pseuderanthemone (<b>1</b>), along with ten known compounds (<b>2</b>–<b>11</b>), was isolated from an ethyl acetate extract of the stems and roots of <i>P. crenulatum</i>. The investigation into their anti-hyperglycemic effects revealed that compounds <b>1–3</b>, and <b>6–10</b> showed higher <i>α</i>-glucosidase inhibitory activity than positive control, acarbose. Among them, compound <b>9</b> demonstrated the most potent activity, with an IC<sub>50</sub> value nearly ten times lower than acarbose. Furthermore, kinetic analysis showed that compound <b>2</b> displayed mixed-type inhibition, and compound <b>3</b> demonstrated uncompetitive inhibition while the remaining compounds exhibited competitive inhibition.</p><h3>Graphical Abstract</h3>\u0000<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 4","pages":"913 - 921"},"PeriodicalIF":2.5,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143957795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dendrobium huoshanense polysaccharide inhibits NSCLC proliferation and immune evasion via FXR1-IL-35 axis signaling pathway 霍山石斛多糖通过FXR1-IL-35轴信号通路抑制NSCLC增殖和免疫逃避。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2025-04-21 DOI: 10.1007/s11418-025-01894-7
Xinying Zhu, Guoquan Yin, Jiaqian Xu, Xiaolei Tang, Fangliu Yu

Dendrobium huoshanense has received special attention for its advantages in the treatment of lung cancer, but the underlying molecular mechanisms are not yet well understood. First, we obtained 8 active ingredients and 159 effective action targets of Dendrobium huoshanense using network pharmacology, and searching target interactions through STRING, constructing the PPI network and KEGG, GO and Hallmark enrichment analysis. Then, we combined target’s enrichment analysis and GSEA enrichment analysis of IL-35, indicating the mechanism of cDHPs for non-small cell lung cancer (NSCLC) may be related to tight junction and NSCLC pathway. Further, FXR1 and ACTR3 were identified as core therapeutic targets, and high expression of FXR1 or ACTR3 was significantly associated with poor prognosis of patients. The analysis of single-cell data also indicated that the percentage of CD4-CTLA4-Treg cells may be increased by the expression of IL-35, resulting in a suppressive immune microenvironment. Next, In vivo experiment, we detected iTr35 by flow cytometry, detected IL-35 level by RT-PCR, Western blotting and ELISA, and detected NK cell activity to explore the immunomodulatory effects and anti-tumor mechanism of cDHPs. After cDHPs administration, the conversion of CD4+ T cells to iTr35 is inhibited, p35 and EBI3 in both protein and mRNA levels, the levels of IL-35 and IL-4 in serum decreased. The levels of IFN-γ, while the activity of NK cells in mice increased, enhancing the anti-tumor immune effect of the organism. Finally, analysis of sequencing data from the immunotherapy cohort of tumor-bearing mice obtained from the TISMO database shows that the combination of cDHPs and PD-1/PD-L1 antibodies improves effector and thus PD-1/PD-L1 antibody efficacy. These findings suggest that cDHPs inhibit NSCLC proliferation and immune escape via the FXR1-IL-35 axis signaling pathway.

Graphical abstract

霍山石斛因其治疗肺癌的优势而备受关注,但其潜在的分子机制尚不清楚。首先,利用网络药理学方法获得霍山石斛的8种有效成分和159个有效作用靶点,并通过STRING搜索靶点相互作用,构建PPI网络,进行KEGG、GO和Hallmark富集分析。然后,我们结合IL-35的靶标富集分析和GSEA富集分析,提示cDHPs治疗非小细胞肺癌(NSCLC)的机制可能与紧密连接和NSCLC通路有关。此外,FXR1和ACTR3被确定为核心治疗靶点,FXR1或ACTR3的高表达与患者预后不良显著相关。单细胞数据分析也表明,CD4-CTLA4-Treg细胞的百分比可能通过IL-35的表达而增加,从而导致免疫微环境的抑制性。接下来,在体内实验中,我们通过流式细胞术检测iTr35, RT-PCR、Western blotting和ELISA检测IL-35水平,检测NK细胞活性,探讨cDHPs的免疫调节作用和抗肿瘤机制。给药后,CD4+ T细胞向iTr35的转化受到抑制,p35和EBI3蛋白和mRNA水平均下降,血清中IL-35和IL-4水平下降。小鼠体内IFN-γ水平升高,同时NK细胞活性增强,增强机体抗肿瘤免疫作用。最后,对TISMO数据库中荷瘤小鼠免疫治疗队列的测序数据分析表明,cDHPs与PD-1/PD-L1抗体联合使用可提高效应,从而提高PD-1/PD-L1抗体的疗效。这些发现提示cDHPs通过FXR1-IL-35轴信号通路抑制NSCLC增殖和免疫逃逸。
{"title":"Dendrobium huoshanense polysaccharide inhibits NSCLC proliferation and immune evasion via FXR1-IL-35 axis signaling pathway","authors":"Xinying Zhu,&nbsp;Guoquan Yin,&nbsp;Jiaqian Xu,&nbsp;Xiaolei Tang,&nbsp;Fangliu Yu","doi":"10.1007/s11418-025-01894-7","DOIUrl":"10.1007/s11418-025-01894-7","url":null,"abstract":"<div><p>Dendrobium huoshanense has received special attention for its advantages in the treatment of lung cancer, but the underlying molecular mechanisms are not yet well understood. First, we obtained 8 active ingredients and 159 effective action targets of Dendrobium huoshanense using network pharmacology, and searching target interactions through STRING, constructing the PPI network and KEGG, GO and Hallmark enrichment analysis. Then, we combined target’s enrichment analysis and GSEA enrichment analysis of IL-35, indicating the mechanism of cDHPs for non-small cell lung cancer (NSCLC) may be related to tight junction and NSCLC pathway. Further, FXR1 and ACTR3 were identified as core therapeutic targets, and high expression of FXR1 or ACTR3 was significantly associated with poor prognosis of patients. The analysis of single-cell data also indicated that the percentage of CD4-CTLA4-Treg cells may be increased by the expression of IL-35, resulting in a suppressive immune microenvironment. Next, In vivo experiment, we detected iTr35 by flow cytometry, detected IL-35 level by RT-PCR, Western blotting and ELISA, and detected NK cell activity to explore the immunomodulatory effects and anti-tumor mechanism of cDHPs. After cDHPs administration, the conversion of CD4<sup>+</sup> T cells to iTr35 is inhibited, p35 and EBI3 in both protein and mRNA levels, the levels of IL-35 and IL-4 in serum decreased. The levels of IFN-γ, while the activity of NK cells in mice increased, enhancing the anti-tumor immune effect of the organism. Finally, analysis of sequencing data from the immunotherapy cohort of tumor-bearing mice obtained from the TISMO database shows that the combination of cDHPs and PD-1/PD-L1 antibodies improves effector and thus PD-1/PD-L1 antibody efficacy. These findings suggest that cDHPs inhibit NSCLC proliferation and immune escape via the FXR1-IL-35 axis signaling pathway.</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 4","pages":"863 - 878"},"PeriodicalIF":2.5,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12228671/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143967686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential of siphonaxanthin, a green algal carotenoid, to prevent obesity and related diseases 绿藻类胡萝卜素siphonaxanthin具有预防肥胖和相关疾病的潜力。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2025-04-12 DOI: 10.1007/s11418-025-01897-4
Yuki Manabe, Tatsuya Sugawara

The increasing prevalence of obesity and its related diseases, including diabetes mellitus and metabolic dysfunction-associated fatty liver disease, has become a significant social problem. These diseases are believed to be preventable through healthy diet and exercise habits, and the investigation of food ingredients that are useful for prevention of these diseases is actively ongoing. Carotenoids are the major lipophilic pigments responsible for yellow-to-red colors in our diet, and the ingestion of certain carotenoids has been reported to prevent obesity. For example, β-carotene suppresses adipogenic differentiation of mouse preadipocyte line 3T3-L1 through its provitamin A activity. Fucoxanthin, a carotenoid found in brown algae, also has the similar effect via a different mechanism and is used as an active ingredient in foods with functional claims in Japan. In contrast, siphonaxanthin, a carotenoid found in some green algae such as Caulerpa lentillifera (commonly known as sea grape), exhibited stronger biological activities than other carotenoids in cell-based studies; it significantly suppressed adipogenic differentiation of 3T3-L1 cells even at low concentrations where β-carotene and fucoxanthin did not show inhibitory effects. However, its practical applications have not yet been realized. This review summarizes the studies on the anti-obesity effects of carotenoids and discusses the potential of siphonaxanthin as a novel functional food ingredient.

Graphical Abstract

肥胖及其相关疾病(包括糖尿病和代谢功能障碍相关的脂肪肝)的患病率日益增加,已成为一个重大的社会问题。这些疾病被认为是可以通过健康的饮食和运动习惯来预防的,对预防这些疾病有用的食物成分的研究正在积极进行中。类胡萝卜素是主要的亲脂色素,在我们的饮食中造成黄到红的颜色,据报道,摄入某些类胡萝卜素可以预防肥胖。例如,β-胡萝卜素通过其维生素A原活性抑制小鼠前脂肪细胞系3T3-L1的成脂分化。褐藻中发现的一种类胡萝卜素岩藻黄质,通过不同的机制也有类似的效果,在日本被用作功能性食品的活性成分。相比之下,在一些绿藻(如Caulerpa lentillifera(俗称海葡萄))中发现的类胡萝卜素siphonaxanthin在细胞基础研究中表现出比其他类胡萝卜素更强的生物活性;在低浓度β-胡萝卜素和岩藻黄素没有抑制作用的情况下,也能显著抑制3T3-L1细胞的成脂分化。然而,它的实际应用尚未实现。本文综述了类胡萝卜素在抗肥胖方面的研究进展,并对siphonaxanthin作为一种新型功能性食品成分的潜力进行了探讨。
{"title":"Potential of siphonaxanthin, a green algal carotenoid, to prevent obesity and related diseases","authors":"Yuki Manabe,&nbsp;Tatsuya Sugawara","doi":"10.1007/s11418-025-01897-4","DOIUrl":"10.1007/s11418-025-01897-4","url":null,"abstract":"<div><p>The increasing prevalence of obesity and its related diseases, including diabetes mellitus and metabolic dysfunction-associated fatty liver disease, has become a significant social problem. These diseases are believed to be preventable through healthy diet and exercise habits, and the investigation of food ingredients that are useful for prevention of these diseases is actively ongoing. Carotenoids are the major lipophilic pigments responsible for yellow-to-red colors in our diet, and the ingestion of certain carotenoids has been reported to prevent obesity. For example, β-carotene suppresses adipogenic differentiation of mouse preadipocyte line 3T3-L1 through its provitamin A activity. Fucoxanthin, a carotenoid found in brown algae, also has the similar effect via a different mechanism and is used as an active ingredient in foods with functional claims in Japan. In contrast, siphonaxanthin, a carotenoid found in some green algae such as <i>Caulerpa lentillifera</i> (commonly known as sea grape), exhibited stronger biological activities than other carotenoids in cell-based studies; it significantly suppressed adipogenic differentiation of 3T3-L1 cells even at low concentrations where β-carotene and fucoxanthin did not show inhibitory effects. However, its practical applications have not yet been realized. This review summarizes the studies on the anti-obesity effects of carotenoids and discusses the potential of siphonaxanthin as a novel functional food ingredient.</p><h3>Graphical Abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 6","pages":"1433 - 1446"},"PeriodicalIF":2.5,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s11418-025-01897-4.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143957284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insight of action mechanism of Astragaloside IV for relieving of cerebral ischemic injury in a rat model of middle cerebral artery occlusion reperfusion via proteomics and network pharmacology 通过蛋白质组学和网络药理学研究黄芪甲苷缓解大鼠大脑中动脉闭塞再灌注模型脑缺血损伤的作用机制
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2025-04-10 DOI: 10.1007/s11418-025-01892-9
Xin-Hua Zhu, Xin Yu, Xiang-Wen Kong, Yi Zhang, Si-Liang Jiang, Jun-Hong Chai, Jun Liang, Hai-Xue Kuang, Yong-Gang Xia

Astragaloside IV (AS-IV) is the principal active component of Astragalus membranaceus (fisch.) Bge. var. mongholicus (Bge.) Hsiao. This study aims to explore action mechanism of AS-IV for relieving of cerebral ischemic injury in a rat model of middle cerebral artery occlusion reperfusion (MCAO) via proteomics and network pharmacology. Pharmacodynamics experiments showed that AS-IV could effectively alleviate MACO-induced cerebral infarction, preserve the structural integrity of neurons, and promote the formation of Sol bodies. In addition, TMT quantitative proteomics revealed differential proteins (DEPs), e.g., DGKQ, PPT1, Gnai3, Gnal, PLA2G4A, and Ppp2ca. These DEPs might be closely related to AS-IV for the therapeutic effects on ischemic stroke. In combination with network pharmacology, the PLA2G4A was further identified as key target protein of AS-IV ascribed to its involvement in the regulation of inflammatory mediators in the TRP pathway. Ultimately, in vitro validation demonstrated that AS-IV offers neuroprotective effects by targeting the PLA2G4A, reducing the release of arachidonic acid (AA) and COX-2, and facilitating Ca2+ inflow into cells. This study provided a scientific basis on development and application of AS-IV for treating ischemic stroke.

Graphical abstract

黄芪甲苷(Astragaloside IV, AS-IV)是黄芪的主要活性成分。知母。蒙古变种(大)萧。本研究旨在通过蛋白质组学和网络药理学方法探讨AS-IV对大鼠大脑中动脉闭塞再灌注(MCAO)模型脑缺血损伤的缓解作用机制。药效学实验表明,AS-IV能有效缓解maco诱导的脑梗死,保持神经元结构完整性,促进Sol小体的形成。此外,TMT定量蛋白质组学发现了差异蛋白(DEPs),如DGKQ、PPT1、Gnai3、Gnal、PLA2G4A和Ppp2ca。这些DEPs可能与AS-IV对缺血性脑卒中的治疗作用密切相关。结合网络药理学,进一步确定PLA2G4A参与TRP通路中炎症介质的调控,是as - iv的关键靶蛋白。最终,体外验证表明,AS-IV通过靶向PLA2G4A,减少花生四烯酸(AA)和COX-2的释放,促进Ca2+流入细胞,具有神经保护作用。本研究为AS-IV治疗缺血性脑卒中的开发和应用提供了科学依据。图形抽象
{"title":"Insight of action mechanism of Astragaloside IV for relieving of cerebral ischemic injury in a rat model of middle cerebral artery occlusion reperfusion via proteomics and network pharmacology","authors":"Xin-Hua Zhu,&nbsp;Xin Yu,&nbsp;Xiang-Wen Kong,&nbsp;Yi Zhang,&nbsp;Si-Liang Jiang,&nbsp;Jun-Hong Chai,&nbsp;Jun Liang,&nbsp;Hai-Xue Kuang,&nbsp;Yong-Gang Xia","doi":"10.1007/s11418-025-01892-9","DOIUrl":"10.1007/s11418-025-01892-9","url":null,"abstract":"<div><p>Astragaloside IV (AS-IV) is the principal active component of <i>Astragalus membranaceus</i> (fisch.) Bge. var. <i>mongholicus</i> (Bge.) Hsiao. This study aims to explore action mechanism of AS-IV for relieving of cerebral ischemic injury in a rat model of middle cerebral artery occlusion reperfusion (MCAO) via proteomics and network pharmacology. Pharmacodynamics experiments showed that AS-IV could effectively alleviate MACO-induced cerebral infarction, preserve the structural integrity of neurons, and promote the formation of Sol bodies. In addition, TMT quantitative proteomics revealed differential proteins (DEPs), e.g., DGKQ, PPT1, Gnai3, Gnal, PLA2G4A, and Ppp2ca. These DEPs might be closely related to AS-IV for the therapeutic effects on ischemic stroke. In combination with network pharmacology, the PLA2G4A was further identified as key target protein of AS-IV ascribed to its involvement in the regulation of inflammatory mediators in the TRP pathway. Ultimately, in <i>vitro</i> validation demonstrated that AS-IV offers neuroprotective effects by targeting the PLA2G4A, reducing the release of arachidonic acid (AA) and COX-2, and facilitating Ca<sup>2+</sup> inflow into cells. This study provided a scientific basis on development and application of AS-IV for treating ischemic stroke.</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 3","pages":"591 - 607"},"PeriodicalIF":2.5,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143918960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tenacissoside G reverses paclitaxel resistance by inhibiting Src/PTN/P-gp signaling axis activation in ovarian cancer cells Tenacissoside G通过抑制卵巢癌细胞Src/PTN/P-gp信号轴激活逆转紫杉醇耐药。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2025-04-08 DOI: 10.1007/s11418-025-01879-6
Jiudong Hu, Yujie Hu, Xiangqi Zhang, Jingxian Zhang, Yangyun Zhou, Xiaohe Wang, Wenhui Wu, Junjun Chen, Yonglong Han

Ovarian cancer (OC) is the most common malignant gynecologic tumor, with the highest mortality rate among female reproductive system cancers. Resistance to chemotherapy drugs, which often develops after long-term use, is a major cause of treatment failure. In recent years, traditional Chinese medicine has been widely used in the treatment of tumor for their advantages in improving the efficacy of chemotherapy and alleviating the toxic side effects. Tenacissoside G (Tsd-G), as one of the main active ingredients of Marsdenia tenacissima, exhibits anti-tumor effects. However, its impact on ovarian cancer is not well understood. To assess the role and mechanism of Tsd-G in reversing paclitaxel (PTX) resistance, the reversal fold of Tsd-G in combination with PTX on OC PTX-resistant (A2780/T) cells was determined using CCK-8 assay. The apoptosis level and migration ability of A2780/T cells after 24 h treatment with Tsd-G and PTX were assessed by Hoechst 33,342, flow cytometry, and wound healing assay. Western Blot and Src overexpression plasmid were used to explore the relationship between Src and PTX resistance. The relationship between Src expression and human OC was analyzed by gene expression database. The effect of Tsd-G on P-gp activity was detected by flow cytometry. Western blot and RT-PCR experiments were performed to detect the differences in mRNA and protein expression of Src/PTN/P-gp signaling axis to validate the mechanism of Tsd-G in reversing the resistance to PTX in ovarian cancer. The results showed that Tsd-G reverses PTX resistance in ovarian cancer cells by regulating cell proliferation, cell cycle, inducing apoptosis, and inhibiting migration. The mechanism might associate with the inhibition of Src expression and phosphorylation activation, which in turn inhibits the expression and activity of downstream PTN and P-gp. This study provides a new idea for the treatment of PTX-resistant OC patients and provides theoretical support for revealing the anti-ovarian cancer active ingredients in Marsdenia tenacissima.

Graphical abstract

Tsd-G reverses PTX resistance by inhibiting the Src/PTN/P-gp signaling axis and inducing PTX accumulation in ovarian cancer paclitaxel-resistant cells.

卵巢癌(OC)是最常见的妇科恶性肿瘤,在女性生殖系统癌症中死亡率最高。长期使用化疗药物后往往产生耐药性,这是治疗失败的主要原因。近年来,中药以其在提高化疗疗效、减轻毒副作用等方面的优势,在肿瘤治疗中得到了广泛的应用。Tenacissoside G (Tsd-G)是tenacissima的主要活性成分之一,具有抗肿瘤作用。然而,其对卵巢癌的影响尚不清楚。为了评估Tsd-G在逆转紫杉醇(PTX)耐药中的作用和机制,采用CCK-8法测定了Tsd-G联合PTX对OC PTX耐药(A2780/T)细胞的逆转折叠。采用Hoechst 33,342、流式细胞术、创面愈合实验检测Tsd-G和PTX作用24h后A2780/T细胞的凋亡水平和迁移能力。采用Western Blot和Src过表达质粒研究Src与PTX耐药的关系。通过基因表达数据库分析Src表达与人类OC的关系。流式细胞术检测Tsd-G对P-gp活性的影响。通过Western blot和RT-PCR检测Src/PTN/P-gp信号轴mRNA和蛋白表达的差异,验证Tsd-G逆转卵巢癌PTX耐药的机制。结果表明,Tsd-G通过调节细胞增殖、细胞周期、诱导凋亡、抑制迁移等途径逆转PTX对卵巢癌细胞的耐药。其机制可能与抑制Src表达和磷酸化激活有关,这反过来又抑制下游PTN和P-gp的表达和活性。本研究为ptx耐药卵巢癌患者的治疗提供了新的思路,并为揭示马筋草抗卵巢癌活性成分提供了理论支持。
{"title":"Tenacissoside G reverses paclitaxel resistance by inhibiting Src/PTN/P-gp signaling axis activation in ovarian cancer cells","authors":"Jiudong Hu,&nbsp;Yujie Hu,&nbsp;Xiangqi Zhang,&nbsp;Jingxian Zhang,&nbsp;Yangyun Zhou,&nbsp;Xiaohe Wang,&nbsp;Wenhui Wu,&nbsp;Junjun Chen,&nbsp;Yonglong Han","doi":"10.1007/s11418-025-01879-6","DOIUrl":"10.1007/s11418-025-01879-6","url":null,"abstract":"<div><p>Ovarian cancer (OC) is the most common malignant gynecologic tumor, with the highest mortality rate among female reproductive system cancers. Resistance to chemotherapy drugs, which often develops after long-term use, is a major cause of treatment failure. In recent years, traditional Chinese medicine has been widely used in the treatment of tumor for their advantages in improving the efficacy of chemotherapy and alleviating the toxic side effects. Tenacissoside G (Tsd-G), as one of the main active ingredients of <i>Marsdenia tenacissima,</i> exhibits anti-tumor effects. However, its impact on ovarian cancer is not well understood. To assess the role and mechanism of Tsd-G in reversing paclitaxel (PTX) resistance, the reversal fold of Tsd-G in combination with PTX on OC PTX-resistant (A2780/T) cells was determined using CCK-8 assay. The apoptosis level and migration ability of A2780/T cells after 24 h treatment with Tsd-G and PTX were assessed by Hoechst 33,342, flow cytometry, and wound healing assay. Western Blot and Src overexpression plasmid were used to explore the relationship between Src and PTX resistance. The relationship between Src expression and human OC was analyzed by gene expression database. The effect of Tsd-G on P-gp activity was detected by flow cytometry. Western blot and RT-PCR experiments were performed to detect the differences in mRNA and protein expression of Src/PTN/P-gp signaling axis to validate the mechanism of Tsd-G in reversing the resistance to PTX in ovarian cancer. The results showed that Tsd-G reverses PTX resistance in ovarian cancer cells by regulating cell proliferation, cell cycle, inducing apoptosis, and inhibiting migration. The mechanism might associate with the inhibition of Src expression and phosphorylation activation, which in turn inhibits the expression and activity of downstream PTN and P-gp. This study provides a new idea for the treatment of PTX-resistant OC patients and provides theoretical support for revealing the anti-ovarian cancer active ingredients in <i>Marsdenia tenacissima</i>.</p><h3>Graphical abstract</h3><p>Tsd-G reverses PTX resistance by inhibiting the Src/PTN/P-gp signaling axis and inducing PTX accumulation in ovarian cancer paclitaxel-resistant cells.</p>\u0000<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 3","pages":"621 - 638"},"PeriodicalIF":2.5,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143802147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibitory effects of reumycin produced by Streptomyces sp. TPMA0082 on virulence factors of Pseudomonas aeruginosa 链霉菌TPMA0082产重霉素对铜绿假单胞菌毒力因子的抑制作用。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2025-04-08 DOI: 10.1007/s11418-025-01902-w
Jiahao Zeng, Yohei Iizaka, Yasuhiro Ouchi, Kouharu Otsuki, Takashi Kikuchi, Wei Li, Yojiro Anzai

Pseudomonas aeruginosa is an opportunistic human pathogen that causes a wide range of infections. The increasing multidrug-resistance of P. aeruginosa poses a critical challenge for medical care. P. aeruginosa employs virulence factors and biofilms to establish infections in humans and protect itself from environmental stress or antibiotics. These factors are regulated by a quorum sensing mechanism involving multiple regulatory systems that act interdependently through signaling molecules. Therefore, interference with quorum sensing systems can suppress the pathogenicity of P. aeruginosa. In this study, quorum sensing inhibitors were explored from secondary metabolites derived from 111 strains of actinomycetes by targeting the las system, which is thought to be upstream of the quorum sensing cascade in P. aeruginosa. As a result, reumycin was isolated from the culture broth of Streptomyces sp. TPMA0082. Reumycin, a molecule containing a pyrimidotriazine ring, inhibited the binding of the autoinducer to the LasR receptor in the las system, thereby suppressing the production of P. aeruginosa virulence factors, including pyocyanin, rhamnolipids, elastase, motility, and biofilms, without affecting bacterial growth. Toxoflavin, a reumycin derivative with a methyl group at the N1 position, exhibited strong antibacterial activity. Fervenulin, a reumycin derivative with a methyl group at the N8 position, had a negative impact on the logarithmic growth phase of the bacteria and exhibited lower inhibitory activity against virulence factor production compared to reumycin. These findings suggest that the position and number of methyl groups attached to the pyrimidotriazine structure significantly influence its biological activity, exerting distinct effects on quorum sensing inhibition and antibacterial activity.

Graphical abstract

铜绿假单胞菌是一种机会性的人类病原体,引起广泛的感染。铜绿假单胞菌日益增加的多药耐药性对医疗保健提出了严峻的挑战。铜绿假单胞菌利用毒力因子和生物膜在人体内建立感染,并保护自己免受环境压力或抗生素的影响。这些因素受群体感应机制的调节,涉及多个调节系统,通过信号分子相互依赖地起作用。因此,干扰群体感应系统可以抑制铜绿假单胞菌的致病性。在这项研究中,我们从111株放线菌的次生代谢物中寻找了群体感应抑制剂,并将las系统作为目标,该系统被认为是P. aeruginosa群体感应级联的上游。结果表明,从链霉菌TPMA0082培养液中分离出了reumycin。Reumycin是一种含有嘧啶三嗪环的分子,它抑制了las系统中自诱导剂与LasR受体的结合,从而抑制了P. aeruginosa毒力因子的产生,包括pyocyanin、鼠李糖脂、弹性酶、运动和生物膜,而不影响细菌的生长。弓形黄素(Toxoflavin)是一种具有N1位甲基的雷霉素衍生物,具有较强的抗菌活性。Fervenulin是一种reumycin的衍生物,在N8位置有一个甲基,对细菌的对数生长期有负面影响,对毒力因子产生的抑制活性低于reumycin。这些结果表明,嘧啶三嗪结构上甲基的位置和数量对其生物活性有显著影响,对群体感应抑制和抗菌活性有明显的影响。
{"title":"Inhibitory effects of reumycin produced by Streptomyces sp. TPMA0082 on virulence factors of Pseudomonas aeruginosa","authors":"Jiahao Zeng,&nbsp;Yohei Iizaka,&nbsp;Yasuhiro Ouchi,&nbsp;Kouharu Otsuki,&nbsp;Takashi Kikuchi,&nbsp;Wei Li,&nbsp;Yojiro Anzai","doi":"10.1007/s11418-025-01902-w","DOIUrl":"10.1007/s11418-025-01902-w","url":null,"abstract":"<div><p><i>Pseudomonas aeruginosa</i> is an opportunistic human pathogen that causes a wide range of infections. The increasing multidrug-resistance of <i>P. aeruginosa</i> poses a critical challenge for medical care. <i>P. aeruginosa</i> employs virulence factors and biofilms to establish infections in humans and protect itself from environmental stress or antibiotics. These factors are regulated by a quorum sensing mechanism involving multiple regulatory systems that act interdependently through signaling molecules. Therefore, interference with quorum sensing systems can suppress the pathogenicity of <i>P. aeruginosa</i>. In this study, quorum sensing inhibitors were explored from secondary metabolites derived from 111 strains of actinomycetes by targeting the <i>las</i> system, which is thought to be upstream of the quorum sensing cascade in <i>P. aeruginosa</i>. As a result, reumycin was isolated from the culture broth of <i>Streptomyces</i> sp. TPMA0082. Reumycin, a molecule containing a pyrimidotriazine ring, inhibited the binding of the autoinducer to the LasR receptor in the <i>las</i> system, thereby suppressing the production of <i>P. aeruginosa</i> virulence factors, including pyocyanin, rhamnolipids, elastase, motility, and biofilms, without affecting bacterial growth. Toxoflavin, a reumycin derivative with a methyl group at the N1 position, exhibited strong antibacterial activity. Fervenulin, a reumycin derivative with a methyl group at the N8 position, had a negative impact on the logarithmic growth phase of the bacteria and exhibited lower inhibitory activity against virulence factor production compared to reumycin. These findings suggest that the position and number of methyl groups attached to the pyrimidotriazine structure significantly influence its biological activity, exerting distinct effects on quorum sensing inhibition and antibacterial activity.</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 3","pages":"608 - 620"},"PeriodicalIF":2.5,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143802199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Processing reduces diester diterpenoid alkaloids content of fuzi products, resulting in reduced toxicity and modified bioactivities 加工降低了附子产品中二酯二萜生物碱的含量,从而降低了毒性和改变了生物活性。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2025-04-07 DOI: 10.1007/s11418-025-01895-6
Tian Xiang, Xiaozhou Yang, Xiaoyao Zhang, Haobo Yuan, Man Xu, Chenxuan Yang, Murtala Bindawa Isah, Chen Chen, Hao Han, Xiaoying Zhang

Fuzi is a generic term for various processed products of the lateral roots of Aconitum carmichaelii Debeaux, with a long history of medicinal use including hypoglycemic, anti-inflammatory, and immunity-enhancing. However, the toxicity of Fuzi limits its widespread use. Different processing methods have been used to minimize toxicity and improve the medicinal properties of Fuzi. Three processed Fuzi products were prepared according to Chinese Pharmacopoeia and their chemical compositions were qualitatively and quantitatively analysed using UPLC-MS. The toxicity, antioxidant properties and bioactivity changes were assessed in Caenorhabditis elegans. A total of 99 compounds were preliminarily identified, and a subsequent multivariate analysis showed significant differences among the different processed products in terms of chemical compositions. The processing led to a significant loss of alkaloids, decrease in the contents of total polyphenols and flavonoids, and a decrease in antioxidant capacity while increasing the total polysaccharide and uronic acid contents in Yan Fuzi and Hei Shunpian as well as the content of monoester diterpenoid alkaloids in Hei Shunpian and Bai Fupian. Furthermore, the processed products prevented cold stress in C. elegans. In conclusion, processing altered the composition and reduced the toxicity of Fuzi and led to differences in the pharmacological activities of different processed Fuzi products. These results provide a theoretical basis for the in-depth pharmacological study and application of processed products of Fuzi.

Graphical abstract

附子是乌头侧根各种加工产品的总称,具有降血糖、抗炎、增强免疫等药用历史。然而,附子的毒性限制了它的广泛使用。采用不同的加工方法来降低附子的毒性,提高其药用性能。按照《中国药典》的规定制备了3种附子炮制品,并用UPLC-MS对其化学成分进行了定性和定量分析。研究了其对秀丽隐杆线虫的毒性、抗氧化性能和生物活性变化。初步鉴定了99种化合物,随后的多变量分析显示,不同加工产品的化学成分存在显著差异。处理后的燕伏子和黑顺片中生物碱含量明显减少,总多酚和总黄酮含量降低,抗氧化能力下降,而黑顺片和白顺片中总多糖和醛酸含量以及单酯二萜生物碱含量均有所增加。此外,加工后的产品可以防止秀丽隐杆线虫的冷应激。综上所述,加工改变了附子的成分,降低了附子的毒性,导致不同加工方式附子产品的药理活性存在差异。这些结果为附子炮制品的深入药理研究和应用提供了理论依据。
{"title":"Processing reduces diester diterpenoid alkaloids content of fuzi products, resulting in reduced toxicity and modified bioactivities","authors":"Tian Xiang,&nbsp;Xiaozhou Yang,&nbsp;Xiaoyao Zhang,&nbsp;Haobo Yuan,&nbsp;Man Xu,&nbsp;Chenxuan Yang,&nbsp;Murtala Bindawa Isah,&nbsp;Chen Chen,&nbsp;Hao Han,&nbsp;Xiaoying Zhang","doi":"10.1007/s11418-025-01895-6","DOIUrl":"10.1007/s11418-025-01895-6","url":null,"abstract":"<div><p>Fuzi is a generic term for various processed products of the lateral roots of <i>Aconitum carmichaelii</i> Debeaux, with a long history of medicinal use including hypoglycemic, anti-inflammatory, and immunity-enhancing. However, the toxicity of Fuzi limits its widespread use. Different processing methods have been used to minimize toxicity and improve the medicinal properties of Fuzi. Three processed Fuzi products were prepared according to Chinese Pharmacopoeia and their chemical compositions were qualitatively and quantitatively analysed using UPLC-MS. The toxicity, antioxidant properties and bioactivity changes were assessed in <i>Caenorhabditis elegans</i>. A total of 99 compounds were preliminarily identified, and a subsequent multivariate analysis showed significant differences among the different processed products in terms of chemical compositions. The processing led to a significant loss of alkaloids, decrease in the contents of total polyphenols and flavonoids, and a decrease in antioxidant capacity while increasing the total polysaccharide and uronic acid contents in Yan Fuzi and Hei Shunpian as well as the content of monoester diterpenoid alkaloids in Hei Shunpian and Bai Fupian. Furthermore, the processed products prevented cold stress in <i>C. elegans</i>. In conclusion, processing altered the composition and reduced the toxicity of Fuzi and led to differences in the pharmacological activities of different processed Fuzi products. These results provide a theoretical basis for the in-depth pharmacological study and application of processed products of Fuzi.</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 3","pages":"695 - 705"},"PeriodicalIF":2.5,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143802146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of the mechanism of Buyang Huanwu decoction in improving learning and memory impairment in Alzheimer's disease mice based on lipidomics 基于脂质组学研究补阳还五汤改善阿尔茨海默病小鼠学习记忆障碍的机制。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2025-04-07 DOI: 10.1007/s11418-025-01890-x
Jing Jiang, Kai Duo, Siyu Zhu, Yitong Wang, Hui Xue, Chengyu Piao, Yifan Ren, Xia Lei, Yafeng Zhang, Jianxin Liu, Lihong Yang, Ning Zhang

In this study, a lipid disorder Alzheimer’s disease (AD) model was developed with high-fat diet and d-galactose injected intraperitoneally (HFD & d-gal) to evaluate the activities of Buyang Huanwu Decoction (BYHWD) compared with donepezil hydrochloride. The learning and memory abilities of BYHWD were evaluated by Morris water maze test (MWM). The lipid levels in serum, histopathology, and immunohistochemistry of hyperphosphorylated tau protein in hippocampal neurons were conducted to prove the therapy effects of BYHWD. After the identification of constituents absorbed into the brain using LC–MS, UPLC-TQ-MS was employed to analyze endogenous lipid metabolites in the hippocampi of mice. Based on the validated differential markers identified through lipidomics analysis, we further substantiated potential therapeutic pathway of BYHWD through the application of molecular docking technology. The mechanism underlying BYHWD was subsequently confirmed by palmitic acid-injured HT22 cells. The results showed that BYHWD significantly improved the cognitive deficits and regulated the lipid levels of HFD & D-gal mice. BYHWD also protected the neuronal cell condition of hippocampal neurons, increased the density of dendritic spines, and reduced the expression of P-tau. Lipidomics revealed that 41 differential lipid metabolites were retuned after BYHWD administration, and this change may be related to the PPARγ pathway. Calycosin-7-glucoside showed good interaction with PPARγ in vivo composition analysis. Calycosin-7-glucoside increased the mRNA expression levels of lipid metabolism-related enzymes and PPARγ, as well as the expression of PPARγ protein in vitro study. BYHWD activated the PPARγ pathway to induce peroxisome proliferation and regulated lipid metabolism disorders in the AD mice brain.

Graphical abstract

本研究采用高脂饮食和腹腔注射d -半乳糖(HFD & D-gal)建立脂质紊乱性阿尔茨海默病(AD)模型,比较补阳还五汤(BYHWD)与盐酸多奈哌齐的活性。采用Morris水迷宫试验(Morris water maze test, MWM)评价大鼠的学习记忆能力。通过血清脂质水平、组织病理学和海马神经元中tau蛋白高磷酸化的免疫组化来证明BYHWD的治疗效果。在LC-MS鉴定入脑成分后,采用UPLC-TQ-MS分析小鼠海马内源性脂质代谢物。基于脂质组学分析鉴定的鉴别标记,我们通过分子对接技术进一步证实了BYHWD的潜在治疗途径。随后,棕榈酸损伤的HT22细胞证实了BYHWD的机制。结果表明,BYHWD显著改善了HFD和D-gal小鼠的认知缺陷,并调节了脂质水平。BYHWD还能保护海马神经元的神经元细胞状态,增加树突棘的密度,降低P-tau的表达。脂质组学显示,服用BYHWD后,有41种不同的脂质代谢物被恢复,这种变化可能与PPARγ途径有关。体内成分分析表明,毛蕊异黄酮-7-葡萄糖苷与PPARγ具有良好的相互作用。体外研究表明,毛蕊异黄酮-7-葡萄糖苷增加了脂质代谢相关酶和PPARγ mRNA表达水平以及PPARγ蛋白的表达。BYHWD激活PPARγ通路,诱导过氧化物酶体增殖,调节AD小鼠脑脂质代谢紊乱。
{"title":"Investigation of the mechanism of Buyang Huanwu decoction in improving learning and memory impairment in Alzheimer's disease mice based on lipidomics","authors":"Jing Jiang,&nbsp;Kai Duo,&nbsp;Siyu Zhu,&nbsp;Yitong Wang,&nbsp;Hui Xue,&nbsp;Chengyu Piao,&nbsp;Yifan Ren,&nbsp;Xia Lei,&nbsp;Yafeng Zhang,&nbsp;Jianxin Liu,&nbsp;Lihong Yang,&nbsp;Ning Zhang","doi":"10.1007/s11418-025-01890-x","DOIUrl":"10.1007/s11418-025-01890-x","url":null,"abstract":"<div><p>In this study, a lipid disorder Alzheimer’s disease (AD) model was developed with high-fat diet and <span>d</span>-galactose injected intraperitoneally (HFD &amp; <span>d</span>-gal) to evaluate the activities of Buyang Huanwu Decoction (BYHWD) compared with donepezil hydrochloride. The learning and memory abilities of BYHWD were evaluated by Morris water maze test (MWM). The lipid levels in serum, histopathology, and immunohistochemistry of hyperphosphorylated tau protein in hippocampal neurons were conducted to prove the therapy effects of BYHWD. After the identification of constituents absorbed into the brain using LC–MS, UPLC-TQ-MS was employed to analyze endogenous lipid metabolites in the hippocampi of mice. Based on the validated differential markers identified through lipidomics analysis, we further substantiated potential therapeutic pathway of BYHWD through the application of molecular docking technology. The mechanism underlying BYHWD was subsequently confirmed by palmitic acid-injured HT22 cells. The results showed that BYHWD significantly improved the cognitive deficits and regulated the lipid levels of HFD &amp; D-gal mice. BYHWD also protected the neuronal cell condition of hippocampal neurons, increased the density of dendritic spines, and reduced the expression of P-tau. Lipidomics revealed that 41 differential lipid metabolites were retuned after BYHWD administration, and this change may be related to the PPARγ pathway. Calycosin-7-glucoside showed good interaction with PPARγ in vivo composition analysis. Calycosin-7-glucoside increased the mRNA expression levels of lipid metabolism-related enzymes and PPARγ, as well as the expression of PPARγ protein in vitro study. BYHWD activated the PPARγ pathway to induce peroxisome proliferation and regulated lipid metabolism disorders in the AD mice brain.</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 3","pages":"568 - 590"},"PeriodicalIF":2.5,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s11418-025-01890-x.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143802143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring new natural products by utilizing untapped secondary metabolic pathways in actinomycetes 利用放线菌未开发的次生代谢途径探索新的天然产物。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2025-04-04 DOI: 10.1007/s11418-025-01903-9
Shotaro Hoshino

Actinomycetes have produced a variety of bioactive secondary metabolites; however, discovering new actinobacterial natural products using conventional approaches has become increasingly challenging. Meanwhile, genomic studies of actinomycetes have revealed that numerous secondary metabolite biosynthetic gene clusters (SM-BGCs) remain untapped. Thus, utilizing these secondary metabolic pathways is expected to facilitate the discovery of new actinomycetes-derived natural products. In this review, I primarily describe our research on the utilization of these untapped actinobacterial SM-BGCs and the discovery of new secondary metabolites. First, I introduce our studies on the activation of silent SM-BGCs through the co-cultivation of various actinomycetes with mycolic acid-containing bacteria (MACB), which led to the identification of 20 actinobacterial secondary metabolites, including 16 new compounds. In the latter part, I describe our recent findings on arsenic-related secondary metabolism, which has been overlooked in model actinomycetes, including the identification of a novel organoarsenic natural product, and the elucidation of its unique biosynthetic strategy, which is independent of S-adenosylmethionine (SAM)-dependent enzymes.

Graphical abstract

放线菌产生了多种具有生物活性的次级代谢产物;然而,利用传统方法发现新的放线菌天然产物已变得越来越具有挑战性。同时,放线菌的基因组研究发现,许多次级代谢物生物合成基因簇(SM-BGCs)仍未被开发。因此,利用这些次级代谢途径有望促进新的放线菌天然产物的发现。在这篇综述中,我将主要介绍我们在利用这些尚未开发的放线菌 SM-BGCs 和发现新的次级代谢产物方面的研究。首先,我介绍了我们通过将各种放线菌与含霉菌酸细菌(MACB)共培养来激活沉默SM-BGCs的研究,从而鉴定出20种放线菌次生代谢产物,包括16种新化合物。在后一部分中,我将介绍我们最近在砷相关次生代谢方面的发现,包括一种新型有机砷天然产物的鉴定,以及对其独立于 S-腺苷蛋氨酸(SAM)依赖酶的独特生物合成策略的阐明。
{"title":"Exploring new natural products by utilizing untapped secondary metabolic pathways in actinomycetes","authors":"Shotaro Hoshino","doi":"10.1007/s11418-025-01903-9","DOIUrl":"10.1007/s11418-025-01903-9","url":null,"abstract":"<div><p>Actinomycetes have produced a variety of bioactive secondary metabolites; however, discovering new actinobacterial natural products using conventional approaches has become increasingly challenging. Meanwhile, genomic studies of actinomycetes have revealed that numerous secondary metabolite biosynthetic gene clusters (SM-BGCs) remain untapped. Thus, utilizing these secondary metabolic pathways is expected to facilitate the discovery of new actinomycetes-derived natural products. In this review, I primarily describe our research on the utilization of these untapped actinobacterial SM-BGCs and the discovery of new secondary metabolites. First, I introduce our studies on the activation of silent SM-BGCs through the co-cultivation of various actinomycetes with mycolic acid-containing bacteria (MACB), which led to the identification of 20 actinobacterial secondary metabolites, including 16 new compounds. In the latter part, I describe our recent findings on arsenic-related secondary metabolism, which has been overlooked in model actinomycetes, including the identification of a novel organoarsenic natural product, and the elucidation of its unique biosynthetic strategy, which is independent of <i>S</i>-adenosylmethionine (SAM)-dependent enzymes.</p><h3>Graphical abstract</h3>\u0000<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 3","pages":"465 - 476"},"PeriodicalIF":2.5,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143778630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chaihu Guizhi Ganjiang Decoction ameliorates chronic pancreatitis by modulating the SK1/S1P signaling pathway 柴胡桂枝肝姜汤通过调节SK1/S1P信号通路改善慢性胰腺炎。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2025-04-03 DOI: 10.1007/s11418-025-01901-x
Guo-Wang Yao, Cai-Xia Li, Yu-Xing Fan, Yu-Zhen Zhuo, Shu-Kun Zhang, Li-Hua Cui

Chronic pancreatitis (CP) is a progressive disease characterized by injury on pancreatic acinar cells (PACs), ongoing fibrosis, and gradual loss of exocrine and endocrine functions. Sphingosine kinase 1 (SK1) expression is elevated in injured PACs, and its metabolite sphingosine-1-phosphate (S1P) promotes the activation of pancreatic stellate cell (PSC) through autophagy and pyroptosis. Chaihu Guizhi Ganjiang Decoction (CGGD), a traditional Chinese medicine is widely used in the clinical treatment of digestive diseases. However, whether CCGD affects the SK1/S1P axis and relieves pancreatic damage through this pathway remains unknown. In this study, CP rats were treated with CGGD, individually or in combination with S1P and SKI-178 for four weeks to assess the effect of CGGD on pancreatic injury, fibrosis, autophagy and pyroptosis. The results showed that SK1, S1P and S1PR2 levels were increased in the pancreatic tissues of CP rats, while CGGD reduced these levels. Treatment with S1P exacerbated histological damage, promoted fibrosis, accelerated autophagy, and induced pyroptosis. Conversely, SKI-178 suppressed these effects. Notably, CGGD mitigated histological damage, decreased serum amylase and lipase levels, and alleviated pancreatic fibrosis induced by S1P. Furthermore, CGGD downregulated autophagy and pyroptosis induced by S1P, exhibiting an effect comparable to SKI-178 in CP. In conclusion, CGGD ameliorates pancreatic damage by reducing fibrosis, inhibiting autophagy, and suppressing pyroptosis through the SK1/S1P axis.

Graphical Abstract

慢性胰腺炎(CP)是一种进行性疾病,其特征是胰腺腺泡细胞(PACs)损伤,持续纤维化,外分泌和内分泌功能逐渐丧失。sphingosin kinase 1 (SK1)在损伤的PACs中表达升高,其代谢物sphingosin -1-phosphate (S1P)通过自噬和焦亡促进胰腺星状细胞(PSC)的活化。柴胡桂枝肝姜汤是临床上广泛应用于消化系统疾病的一种中药。然而,CCGD是否通过这一途径影响SK1/S1P轴并减轻胰腺损伤尚不清楚。本研究采用CGGD单独或联合S1P、SKI-178治疗CP大鼠4周,观察CGGD对胰腺损伤、纤维化、自噬和焦亡的影响。结果显示,CP大鼠胰腺组织中SK1、S1P和S1PR2水平升高,而CGGD降低了这些水平。S1P治疗加重组织损伤,促进纤维化,加速自噬,诱导焦亡。相反,SKI-178抑制了这些作用。CGGD明显减轻组织损伤,降低血清淀粉酶和脂肪酶水平,减轻S1P诱导的胰腺纤维化。此外,CGGD下调S1P诱导的自噬和焦亡,其作用与CP中的SKI-178相当。综上所述,CGGD通过SK1/S1P轴减少纤维化、抑制自噬和抑制焦亡来改善胰腺损伤。
{"title":"Chaihu Guizhi Ganjiang Decoction ameliorates chronic pancreatitis by modulating the SK1/S1P signaling pathway","authors":"Guo-Wang Yao,&nbsp;Cai-Xia Li,&nbsp;Yu-Xing Fan,&nbsp;Yu-Zhen Zhuo,&nbsp;Shu-Kun Zhang,&nbsp;Li-Hua Cui","doi":"10.1007/s11418-025-01901-x","DOIUrl":"10.1007/s11418-025-01901-x","url":null,"abstract":"<div><p>Chronic pancreatitis (CP) is a progressive disease characterized by injury on pancreatic acinar cells (PACs), ongoing fibrosis, and gradual loss of exocrine and endocrine functions. Sphingosine kinase 1 (SK1) expression is elevated in injured PACs, and its metabolite sphingosine-1-phosphate (S1P) promotes the activation of pancreatic stellate cell (PSC) through autophagy and pyroptosis. Chaihu Guizhi Ganjiang Decoction (CGGD), a traditional Chinese medicine is widely used in the clinical treatment of digestive diseases. However, whether CCGD affects the SK1/S1P axis and relieves pancreatic damage through this pathway remains unknown. In this study, CP rats were treated with CGGD, individually or in combination with S1P and SKI-178 for four weeks to assess the effect of CGGD on pancreatic injury, fibrosis, autophagy and pyroptosis. The results showed that SK1, S1P and S1PR2 levels were increased in the pancreatic tissues of CP rats, while CGGD reduced these levels. Treatment with S1P exacerbated histological damage, promoted fibrosis, accelerated autophagy, and induced pyroptosis. Conversely, SKI-178 suppressed these effects. Notably, CGGD mitigated histological damage, decreased serum amylase and lipase levels, and alleviated pancreatic fibrosis induced by S1P. Furthermore, CGGD downregulated autophagy and pyroptosis induced by S1P, exhibiting an effect comparable to SKI-178 in CP. In conclusion, CGGD ameliorates pancreatic damage by reducing fibrosis, inhibiting autophagy, and suppressing pyroptosis through the SK1/S1P axis.</p><h3>Graphical Abstract</h3>\u0000<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 3","pages":"706 - 720"},"PeriodicalIF":2.5,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143770873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Natural Medicines
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1